Annual Drug Patent Expirations for AIRDUO+RESPICLICK
Airduo Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from three suppliers. There are twenty patents protecting this drug.
Drug patent litigation for AIRDUO RESPICLICK.
This drug has three hundred and sixty patent family members in thirty-six countries.
The generic ingredient in AIRDUO RESPICLICK is fluticasone propionate; salmeterol xinafoate. Three suppliers are listed for this compound. Additional details are available on the fluticasone propionate; salmeterol xinafoate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
